Literature DB >> 30385719

Oxidative stress creates a unique, CaMKII-mediated substrate for atrial fibrillation in heart failure.

Shin Yoo1, Gary Aistrup1, Yohannes Shiferaw2, Jason Ng1, Peter J Mohler3, Thomas J Hund3, Trent Waugh1, Suzanne Browne1, Georg Gussak1, Mehul Gilani1, Bradley P Knight1, Rod Passman1, Jeffrey J Goldberger1, J Andrew Wasserstrom1, Rishi Arora1.   

Abstract

The precise mechanisms by which oxidative stress (OS) causes atrial fibrillation (AF) are not known. Since AF frequently originates in the posterior left atrium (PLA), we hypothesized that OS, via calmodulin-dependent protein kinase II (CaMKII) signaling, creates a fertile substrate in the PLA for triggered activity and reentry. In a canine heart failure (HF) model, OS generation and oxidized-CaMKII-induced (Ox-CaMKII-induced) RyR2 and Nav1.5 signaling were increased preferentially in the PLA (compared with left atrial appendage). Triggered Ca2+ waves (TCWs) in HF PLA myocytes were particularly sensitive to acute ROS inhibition. Computational modeling confirmed a direct relationship between OS/CaMKII signaling and TCW generation. CaMKII phosphorylated Nav1.5 (CaMKII-p-Nav1.5 [S571]) was located preferentially at the intercalated disc (ID), being nearly absent at the lateral membrane. Furthermore, a decrease in ankyrin-G (AnkG) in HF led to patchy dropout of CaMKII-p-Nav1.5 at the ID, causing its distribution to become spatially heterogeneous; this corresponded to preferential slowing and inhomogeneity of conduction noted in the HF PLA. Computational modeling illustrated how conduction slowing (e.g., due to increase in CaMKII-p-Nav1.5) interacts with fibrosis to cause reentry in the PLA. We conclude that OS via CaMKII leads to substrate for triggered activity and reentry in HF PLA by mechanisms independent of but complementary to fibrosis.

Entities:  

Keywords:  Arrhythmias; Calcium signaling; Cardiology; Ion channels

Mesh:

Substances:

Year:  2018        PMID: 30385719      PMCID: PMC6238754          DOI: 10.1172/jci.insight.120728

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  79 in total

1.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

Authors:  D Li; S Fareh; T K Leung; S Nattel
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

2.  Regulation of the transient outward K(+) current by Ca(2+)/calmodulin-dependent protein kinases II in human atrial myocytes.

Authors:  S Tessier; P Karczewski; E G Krause; Y Pansard; C Acar; M Lang-Lazdunski; J J Mercadier; S N Hatem
Journal:  Circ Res       Date:  1999-10-29       Impact factor: 17.367

3.  Role of CaMKII in RyR leak, EC coupling and action potential duration: a computational model.

Authors:  Yasmin L Hashambhoy; Joseph L Greenstein; Raimond L Winslow
Journal:  J Mol Cell Cardiol       Date:  2010-07-23       Impact factor: 5.000

Review 4.  NADPH oxidases and cardiac remodelling.

Authors:  Adam Nabeebaccus; Min Zhang; Ajay M Shah
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

5.  Genetic suppression of atrial fibrillation using a dominant-negative ether-a-go-go-related gene mutant.

Authors:  Radim Soucek; Dierk Thomas; Kamilla Kelemen; Olympia Bikou; Claudia Seyler; Frederik Voss; Rüdiger Becker; Michael Koenen; Hugo A Katus; Alexander Bauer
Journal:  Heart Rhythm       Date:  2011-09-09       Impact factor: 6.343

6.  Inositol-1,4,5-trisphosphate induced Ca2+ release and excitation-contraction coupling in atrial myocytes from normal and failing hearts.

Authors:  Felix Hohendanner; Stefanie Walther; Joshua T Maxwell; Sarah Kettlewell; Sawsan Awad; Godfrey L Smith; Vassyl A Lonchyna; Lothar A Blatter
Journal:  J Physiol       Date:  2014-12-22       Impact factor: 5.182

7.  Electrical conduction in canine pulmonary veins: electrophysiological and anatomic correlation.

Authors:  Mélèze Hocini; Siew Y Ho; Tokuhiro Kawara; André C Linnenbank; Mark Potse; Dipen Shah; Pierre Jaïs; Michiel J Janse; Michel Haïssaguerre; Jacques M T De Bakker
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690

Review 8.  Redox regulation of cardiac calcium channels and transporters.

Authors:  Aleksey V Zima; Lothar A Blatter
Journal:  Cardiovasc Res       Date:  2006-03-06       Impact factor: 10.787

9.  PDZ domain-binding motif regulates cardiomyocyte compartment-specific NaV1.5 channel expression and function.

Authors:  Diana Shy; Ludovic Gillet; Jakob Ogrodnik; Maxime Albesa; Arie O Verkerk; Rianne Wolswinkel; Jean-Sébastien Rougier; Julien Barc; Maria C Essers; Ninda Syam; Roos F Marsman; Anneke M van Mil; Samuel Rotman; Richard Redon; Connie R Bezzina; Carol Ann Remme; Hugues Abriel
Journal:  Circulation       Date:  2014-06-03       Impact factor: 29.690

10.  Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins.

Authors:  Svetlana N Reilly; Raja Jayaram; Keshav Nahar; Charalambos Antoniades; Sander Verheule; Keith M Channon; Nicholas J Alp; Ulrich Schotten; Barbara Casadei
Journal:  Circulation       Date:  2011-08-15       Impact factor: 29.690

View more
  14 in total

Review 1.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.

Authors:  Stanley Nattel; Jordi Heijman; Liping Zhou; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 2.  Genetic and non-genetic risk factors associated with atrial fibrillation.

Authors:  Lindsay J Young; Steve Antwi-Boasiako; Joel Ferrall; Loren E Wold; Peter J Mohler; Mona El Refaey
Journal:  Life Sci       Date:  2022-04-03       Impact factor: 6.780

3.  Attenuation of Oxidative Injury With Targeted Expression of NADPH Oxidase 2 Short Hairpin RNA Prevents Onset and Maintenance of Electrical Remodeling in the Canine Atrium: A Novel Gene Therapy Approach to Atrial Fibrillation.

Authors:  Shin Yoo; Anna Pfenniger; Jacob Hoffman; Wenwei Zhang; Jason Ng; Amy Burrell; David A Johnson; Georg Gussak; Trent Waugh; Suzanne Bull; Brandon Benefield; Bradley P Knight; Rod Passman; J Andrew Wasserstrom; Gary L Aistrup; Rishi Arora
Journal:  Circulation       Date:  2020-07-20       Impact factor: 39.918

4.  Serum Total Antioxidant Capacity and Enzymatic Defence of Dogs with Chronic Heart Failure and Atrial Fibrillation: A Preliminary Study.

Authors:  Marcin Michałek; Aleksandra Tabiś; Agnieszka Noszczyk-Nowak
Journal:  J Vet Res       Date:  2020-07-28       Impact factor: 1.744

5.  Oxidized CaMKII and O-GlcNAcylation cause increased atrial fibrillation in diabetic mice by distinct mechanisms.

Authors:  Olurotimi O Mesubi; Adam G Rokita; Neha Abrol; Yuejin Wu; Biyi Chen; Qinchuan Wang; Jonathan M Granger; Anthony Tucker-Bartley; Elizabeth D Luczak; Kevin R Murphy; Priya Umapathi; Partha S Banerjee; Tatiana N Boronina; Robert N Cole; Lars S Maier; Xander H Wehrens; Joel L Pomerantz; Long-Sheng Song; Rexford S Ahima; Gerald W Hart; Natasha E Zachara; Mark E Anderson
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

6.  Oxidative stress: a bystander or a causal contributor to atrial remodelling and fibrillation?

Authors:  Dobromir Dobrev; Samuel C Dudley
Journal:  Cardiovasc Res       Date:  2021-09-28       Impact factor: 10.787

7.  CaMKII inhibition reduces arrhythmogenic Ca2+ events in subendocardial cryoinjured rat living myocardial slices.

Authors:  Eef Dries; Ifigeneia Bardi; Raquel Nunez-Toldra; Bram Meijlink; Cesare M Terracciano
Journal:  J Gen Physiol       Date:  2021-05-06       Impact factor: 4.086

8.  Nucleoplasmic Ca2+: The 'Mastermind' Behind Pathological Atrial Remodeling?

Authors:  Anna Pfenniger; Shin Yoo; Rishi Arora
Journal:  Circ Res       Date:  2021-03-04       Impact factor: 23.213

Review 9.  Atrial Myopathy.

Authors:  Mark J Shen; Rishi Arora; José Jalife
Journal:  JACC Basic Transl Sci       Date:  2019-09-23

Review 10.  CaMKII in Regulation of Cell Death During Myocardial Reperfusion Injury.

Authors:  Yingjie Yang; Kai Jiang; Xu Liu; Mu Qin; Yaozu Xiang
Journal:  Front Mol Biosci       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.